WCDDA Executive Cabinet Minutes

Executive Cabinet Minutes
March 19, 2004

West Coast Dental Association

Members Present: Raed Al Kasem, Nolan Allen, Nick Dundee, Michael Evans, Robert Hart, Betty Hughes, Michael Kirsch, Charles Llano, Paul Miller, John Paul, Rose Rosanelli, Hans Salheiser, John Thee, Hugh Wunderlich, George Yatros, and Steve Zuknick

Members Not Present: William Aughton, Terry Buckenheimer David Campbell, Paul Horton, Joslyn Jenkins, Jeffrey Joffe, Bryan Marshall, Jeffrey Stein, William Truax, and Donald Wexler.

Call to Order: The Executive Cabinet of the West Coast District Dental Association was called to order at 1:15 p.m. on Friday, March 19, 2004 at the West Coast office in Tampa with Dr. Paul Miller, President, presiding.

Invocation: Dr. Michael Evans led in the invocation.

Americanism: Dr. Hugh Wunderlich led the pledge.

Quorum Call & Conflict of Interest & Antitrust Statement: Attendees were reminded of conflict of interest statement and notified president meeting has quorum.

Opening Remarks, President’s Report, and Recognition of Guests: Dr. Miller thanked everyone for coming; everyone introduced himself or herself. Dr. Miller requested an open format while discussing the Annual Meeting in order to allow for new ideas to be shared.

Florida Dental Association Report: Dr. Allen reported legislature is in session and dentists have been asked to make phone calls to their peers. Dentist’s Day on the Hill details was shared. FNDC information was also discussed. Board of Trustees conference call update: land purchase to be pursued, bio-terrorism concern has been discussed with Department of Health, Governance Committee has met again and will be presenting information to the Board of Trustees and to the HOD in June.

Approval Of Minutes: Motion moved to adopt the minutes, adopted unanimously.

Treasurer’s Report: A-C: Reports were presented and reviewed; Dr. Miller explained the WCDDA Fund and it’s purpose.

Additional Agenda Items: A. Reference Committee Policy B. Annual Meeting Strategic Plan C. Calendar of Dates

Adoption of Agenda: Motion moved to adopt agenda, adopted unanimously.

Unfinished Business: none

New Business:

A. Membership:

1. Report & Necrology: Dr. Hugh Wunderlich presented report with membership total 1864. Moment of silence was observed for Drs. Samuel Bradshaw, Frank Gore, Abbott Kagan, Robert Martin, Armando Messina, Clarence Miller, James Mixson, H. Morgan Richards, J. Leon Schwartz, Richard Smith, and Donald Turnquist who expired.

2. Retired Membership Waivers: Waiver for Retired Membership for Dr. Paul Sittelbing and David Winkler, motion to approve, seconded, passed. Waiver for Membership Dues for Drs. Thomas Averitt, Jerome Brown, Stephen Eingorn, and Markus Sherry, motion to approve, seconded, passed unanimously.

3. Automatic Members: Report acknowledged two automatic members. 4. Executive Session: Candidates for membership.

B. Foundation Update:

1. WCDDA Annual Donation Policy: Motion to research through accountant after April 15th, transaction to foundation from West Coast account. Seconded, passed. Report to next Cabinet Meeting.

2. Report: Handout presented on events and ideas.

3. Donation Request: Move to send to the Council On Dental Health, FDA level.

C. ADA Campaign Donation: Motion to donate $2,500.00 for Dr. Robert Ferris campaign for ADA position, seconded, passed.

2004 Annual Summer Meeting: Register for rooms, as per last newsletter, Dr. Dean Morton will be speaking about implants.

Reference Committee Policy Change: Motion made to change policy, motion to amend the change, motion made to accept amendment, seconded passed. Policy adopted:
The two Delegation Co-Chairs will appoint three WCDDA leaders with approval of the president and/or the president-elect, one to attend each reference committee meeting following the first session of the FDA House of Delegates. The appointed reference committee individuals must be available to the Caucus Conference Call prior to the FDA House of Delegates and at the Breakfast Caucus prior to the second session of the FDA House of Delegates.

Meeting adjourned next Cabinet Meeting September 21, 2004.